RT @Oncotarget: #UVSafety #PaperoftheDay: "Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade…
#UVSafety #PaperoftheDay: "Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma" https://t.co/L0ExSuTJNL #melanoma #skincancer #openaccess #medicine #cancer
#UVSafety #PaperoftheDay: "Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma" https://t.co/1Z7zPxmr3K #skincancer #melanoma #openaccess #cancerresearch #m
RT @sciterefcheck: We've detected a paper from Oncotarget that cites a retracted paper post-retraction. Citing paper: https://t.co/fUWvr0V…
We've detected a paper from Oncotarget that cites a retracted paper post-retraction. Citing paper: https://t.co/fUWvr0V4AL Retracted paper: https://t.co/vJ4Lfj2dnb
RT @ColumbiaEpicure: Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted th…
RT @ColumbiaEpicure: Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted th…
RT @ColumbiaEpicure: Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted th…
RT @ColumbiaEpicure: Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted th…
Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma https://t.co/OfnZUbnRdV congratulations @rolopl
RT @Oncotarget: The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B…
RT @Oncotarget: The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B…
RT @Oncotarget: The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B…
RT @Oncotarget: The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B…
RT @Oncotarget: The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B…
The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B16 model of metastases," by Pérez-Lorenzo, et al. https://t.co/FmnATGJIbk